MarketCap
Facebook
X
Telegram
BioVie Kurzfristige Verbindlichkeiten | BIVI
Kurzfristige Verbindlichkeiten Jährlich BioVie
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.27 M | 9.35 M | 14.5 M | 4.17 M | 996 K | 23.5 M | 443 K | 1.24 M | 631 K | 803 K | 324 K | 161 K | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 23.5 M | 161 K | 4.87 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Titan Pharmaceuticals
TTNP
|
483 K | - | -3.76 % | $ 3.47 M |  USA |
 |
Lineage Cell Therapeutics
LCTX
|
11.4 M | $ 1.02 | 3.75 % | $ 235 M | USA |
 |
Longeveron
LGVN
|
4.09 M | $ 1.82 | 6.43 % | $ 32 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
15.7 M | - | 3.16 % | $ 1.9 M | USA |
 |
TCR2 Therapeutics
TCRR
|
64.1 M | - | - | $ 58.1 M | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
85.1 M | $ 84.95 | 0.13 % | $ 7.99 B | USA |
 |
Mustang Bio
MBIO
|
7.91 M | $ 0.39 | 0.15 % | $ 1.91 M | USA |
 |
TFF Pharmaceuticals
TFFP
|
2.43 M | - | -60.05 % | $ 125 K | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.73 M | $ 1.63 | 1.87 % | $ 2.68 M |  Israel |
 |
Mirum Pharmaceuticals
MIRM
|
206 M | $ 93.81 | 0.28 % | $ 4.71 B | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
64.5 M | - | -15.15 % | $ 60.3 M |  Britain |
 |
AVEO Pharmaceuticals
AVEO
|
18.7 M | - | - | $ 521 M | USA |
 |
Codexis
CDXS
|
25.3 M | $ 1.09 | 6.37 % | $ 95 M | USA |
 |
MannKind Corporation
MNKD
|
171 M | $ 3.91 | 4.0 % | $ 1.2 B | USA |
 |
MediciNova
MNOV
|
3.8 M | $ 1.44 | -0.69 % | $ 70.7 M | USA |
 |
Axcella Health
AXLA
|
14.1 M | - | -16.42 % | $ 249 M | USA |
 |
Merck & Co.
MRK
|
28.3 B | $ 146.81 | -0.07 % | $ 367 B | USA |
 |
Dynavax Technologies Corporation
DVAX
|
78.6 M | - | - | $ 2.02 B | USA |
 |
Tyme Technologies
TYME
|
7.39 M | - | 8.07 % | $ 54 M | USA |
 |
Curis
CRIS
|
14.1 M | $ 0.88 | 3.67 % | $ 11.6 M | USA |
 |
Cyclerion Therapeutics
CYCN
|
1.71 M | $ 34.99 | 3.77 % | $ 147 M | USA |
 |
Завод ДИОД
DIOD
|
105 M | - | - | - |  Russia |
 |
CorMedix
CRMD
|
174 M | $ 5.31 | 1.43 % | $ 383 K | USA |
 |
CRISPR Therapeutics AG
CRSP
|
149 M | $ 50.09 | 3.15 % | $ 4.5 B |  Schweiz |
 |
PDS Biotechnology Corporation
PDSB
|
9.48 M | $ 1.22 | 4.27 % | $ 56.6 M | USA |
 |
Pfizer
PFE
|
37 B | $ 29.39 | -0.22 % | $ 167 B | USA |
 |
Orgenesis
ORGS
|
26.9 M | - | -33.86 % | $ 61.2 M | USA |
 |
Cytokinetics, Incorporated
CYTK
|
202 M | $ 53.74 | -3.26 % | $ 6.45 M | USA |
 |
Фармсинтез
LIFE
|
1.02 B | - | - | - | Russia |
 |
Prothena Corporation plc
PRTA
|
40.8 M | $ 7.93 | 0.51 % | $ 427 M | USA |
 |
Codiak BioSciences
CDAK
|
27.2 M | - | -55.98 % | $ 2.15 M | USA |
 |
DBV Technologies S.A.
DBVT
|
58 M | $ 10.54 | 7.55 % | $ 1.47 B |  France |
 |
Rocket Pharmaceuticals
RCKT
|
30.2 M | $ 2.38 | -2.05 % | $ 264 M | USA |
 |
Regeneron Pharmaceuticals
REGN
|
4.37 B | $ 904.69 | 0.2 % | $ 94.6 B | USA |
 |
Replimune Group
REPL
|
58.2 M | $ 21.67 | 8.24 % | $ 2.01 B | USA |
 |
DiaMedica Therapeutics
DMAC
|
5.13 M | $ 9.47 | 4.76 % | $ 445 M | USA |
 |
Royalty Pharma plc
RPRX
|
636 M | $ 67.31 | -0.39 % | $ 28.9 B | USA |
 |
Checkpoint Therapeutics
CKPT
|
20.1 M | - | - | $ 169 M | USA |
 |
Rhythm Pharmaceuticals
RYTM
|
106 M | $ 111.51 | 6.18 % | $ 7.25 B | USA |
 |
Puma Biotechnology
PBYI
|
81.3 M | $ 8.28 | -15.25 % | $ 414 M | USA |
 |
SIGA Technologies
SIGA
|
18 M | $ 3.12 | 4.55 % | $ 223 M | USA |
 |
Sage Therapeutics
SAGE
|
71.6 M | - | - | $ 527 M | USA |
 |
Taro Pharmaceutical Industries Ltd.
TARO
|
386 M | - | - | $ 1.62 B | Israel |
 |
Sol-Gel Technologies Ltd.
SLGL
|
6.17 M | $ 61.62 | -2.21 % | $ 172 M | Israel |
 |
SELLAS Life Sciences Group
SLS
|
7.02 M | $ 8.41 | 6.73 % | $ 917 M | USA |
 |
Summit Therapeutics
SMMT
|
73 M | $ 16.34 | 15.15 % | $ 12.2 B | Britain |